NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00309556,Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer,https://clinicaltrials.gov/study/NCT00309556,,COMPLETED,"Primarily, this clinical investigation compares the rates (percentages) of pathological complete remissions attained at the time of final surgery following 6 cycles each of epirubicin + docetaxel + capecitabine-containing chemotherapy ± trastuzumab (in HER-2 positive disease) vs. epirubicin + docetaxel-containing chemotherapy ± trastuzumab (in HER-2 negative disease).",NO,Breast Cancer,DRUG: Epirubicin|DRUG: Docetaxel|DRUG: Capecitabine|DRUG: Trastuzumab,"Rate of pathological complete remissions, at the time of final surgery after 6 cycles of Arm A (Epirubicin/ Docetaxel/ Capecitabine-containing chemotherapy ± Trastuzumab in HER-2 positive disease) vs. Arm B (Epirubicin/Docetaxel-containing chemotherapy ± Trastuzumab in HER-2 positive disease)., 20 weeks","Rates of axillary lymph node involvement and breast-conserving procedures, at the time of final surgery in Arm A (± trastuzumab in HER-2 positive disease) vs. Arm B (± trastuzumab in HER-2 positive disease)., 20 weeks",,Austrian Breast & Colorectal Cancer Study Group,Amgen|Ebewe Pharma GmbH|Hoffmann-La Roche|Sanofi,FEMALE,"ADULT, OLDER_ADULT",PHASE3,536,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ABCSG-24|Ro 09-1978,2005-02,2009-11,2011-11,2006-04-03,,2011-12-30,"Hospital Guessing, Guessing, Burgenland, 7540, Austria|Hospital Oberpullendorf, Oberpullendorf, Burgenland, 7350, Austria|Hospital Oberwart, Oberwart, Burgenland, 7400, Austria|State Hospital Klagenfurt, Klagenfurt, Carinthia, 9026, Austria|Ordination Dr. Wette, St. Veit a. d. Glan, Carinthia, 9300, Austria|Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, 9330, Austria|State Hospital Villach, Villach, Carinthia, 9500, Austria|State Hospital Wolfsberg, Wolfsberg, Carinthia, 9400, Austria|Hospital Baden, Baden bei Wien, Lower Austria, 2500, Austria|Hospital Krems, Krems, Lower Austria, 3500, Austria|Hospital of Wiener Neustadt, Wiener Neustadt, Lower Austria, 2700, Austria|Gynaegological Medical University Graz, Graz, Styria, 8036, Austria|Medical University of Graz, Oncology, Graz, Styria, 8036, Austria|State Hospital Leoben, Leoben, Styria, 8700, Austria|Medical University of Innsbruck, Innsbruck, Tyrol, 6020, Austria|District Hospital Kufstein, Kufstein, Tyrol, 6330, Austria|State Hospital Kirchdorf, Kirchdorf, Upper Austria, 4560, Austria|Hospital BHS Linz, Linz, Upper Austria, 4010, Austria|General Hospital Linz, Linz, Upper Austria, 4020, Austria|State Hospital Steyr, Steyr, Upper Austria, 4400, Austria|Klinikum Wels-Grieskirchen, Wels, Upper Austria, 4600, Austria|State Hospital Feldkirch/Rankweil, Rankweil, Vorarlberg, 6807, Austria|Paracelsus Medical University Salzburg - Oncology, Salzburg, 5020, Austria|Medical University Vienna, General Hospital, Vienna, 1090, Austria|State Hospital Vienna-Hietzing, Vienna, 1130, Austria|Hanusch Hospital, Vienna, 1140, Austria",
